Patents Assigned to Merck Patents GmbH
  • LIQUID-CRYSTALLINE MEDIUM
    Publication number: 20160208170
    Abstract: The invention relates to a liquid-crystalline medium which comprises the compound of the formula I, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PM-VA, SS-VA, PALC, IPS, PS-IPS, FFS or PS-FFS effect.
    Type: Application
    Filed: January 20, 2016
    Publication date: July 21, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Harald Hirschmann, Martina Windhorst, I
  • PRINTED IMAGE
    Publication number: 20160207344
    Abstract: The present invention relates to a printed image comprising flake-form effect pigments which has striking matt/gloss effects, to a process for the production of a printed image of this type, and to the use thereof, in particular in security printing.
    Type: Application
    Filed: July 25, 2014
    Publication date: July 21, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Sylke KLEIN, Heidemarie MONTAG
  • ALKINYL-TOLANES, LIQUID-CRYSTAL MIXTURES CONTAINING THEM AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY
    Publication number: 20160208167
    Abstract: The present invention relates to compounds of the formula I in which the parameters have the respective meanings given in the description, to the use thereof for high-frequency components, to liquid-crystalline media comprising the compounds, and to high-frequency components, in particular antennae, especially for the gigahertz range, comprising these media. The liquid-crystalline media serve, for example, for the phase shifting of microwaves for tunable ‘phased-array’ antennae.
    Type: Application
    Filed: August 11, 2014
    Publication date: July 21, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Christian JASPER, Constanze BROCKE, Detlef PAULUTH, Volker REIFFENRATH, Atsutaka MANABE
  • Metal Complexes
    Publication number: 20160211468
    Abstract: The present invention relates to metal complexes, to compositions and formulations comprising these complexes, and to devices comprising the complexes or compositions.
    Type: Application
    Filed: July 25, 2014
    Publication date: July 21, 2016
    Applicant: Merck Patent GmbH
    Inventors: Heinrich Becker, Frank Voges
  • PHL P 5A DERIVATIVES HAVING REDUCED ALLERGENEITY AND RETAINED T-CELL REACTIVITY
    Publication number: 20160207967
    Abstract: The present invention relates to the preparation and use of variants of the group 5 allergen of the Pooideae which are characterised by reduced IgE reactivity compared with the known wild-type allergens and at the same time by substantially retained reactivity with T lymphocytes. These hypoallergenic allergen variants can be employed for the specific immunotherapy (hyposensitisation) of patients having grass pollen allergy or for the preventative immunotherapy of grass pollen allergies.
    Type: Application
    Filed: April 5, 2016
    Publication date: July 21, 2016
    Applicant: Merck Patent GmbH
    Inventors: Martin WALD, Oliver CROMWELL, Andreas NANDY, Helga KAHLERT, Bernhard WEBER, Helmut FIEBIG
  • PRECURSORS FOR THE PRODUCTION OF THIN OXIDE LAYERS AND THE USE THEREOF
    Publication number: 20160208386
    Abstract: The present invention relates to novel precursors in the form of metal complexes with 2-substituted 1,3-diketones and to a process for the preparation thereof. The invention furthermore relates to the use thereof for the production of thin metal-oxide layers. The latter are constituents in a very wide variety of electronic components and devices having various functions.
    Type: Application
    Filed: August 4, 2014
    Publication date: July 21, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Klaus BONRAD, Joerg SCHNEIDER, Rudolf HOFFMAN, Mareiki KALOUMENOS
  • Polymers containing substituted benzodithiophene units, blends comprising these polymers, and devices comprising these polymers or blends
    Patent number: 9394406
    Abstract: The present invention relates to polymers containing substituted benzodithiophene units and to blends which comprise the polymers according to the invention. The invention is also directed to the use of the polymers and blends according to the invention in organic electronic devices and to these devices themselves.
    Type: Grant
    Filed: July 19, 2011
    Date of Patent: July 19, 2016
    Assignee: Merck Patent GmbH
    Inventors: Rémi Manouk Anémian, Aurélie Ludemann
  • PHOSPHORS
    Publication number: 20160200973
    Abstract: The invention relates to compounds containing an anionic skeleton structure, dopants and cations, where a. the anionic skeleton structure is characterised by coordination tetrahedra GL4?, where G stands for silicon, and L stands for N and O, b. the cations are selected from the alkaline-earth metals, c. the dopant present is trivalent cerium or a mixture of trivalent cerium and divalent europium, d. the charge compensation of the cerium doping takes place i) via corresponding replacement of alkaline-earth metal cations by alkali-metal cations and/or ii) via a corresponding increase in the nitrogen content and/or iii) via a corresponding reduction in the cations, to a process for the preparation of these compounds, and to the use thereof as conversion phosphors.
    Type: Application
    Filed: December 2, 2013
    Publication date: July 14, 2016
    Applicant: Merck Patent GmbH
    Inventors: Holger WINKLER, Ralf PETRY, Tim VOSGROENE, Christof HAMPEL, Andreas BENKER
  • 3-SUBSTITUTED CYCLOPENTYLAMINE DERIVATIVES
    Publication number: 20160200714
    Abstract: Compounds of the formula I in which R, W, R1, R4, X1, X2, X3, X4 and q have the meanings indicated in claim 1, are inhibitors of fatty acid synthase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
    Type: Application
    Filed: May 12, 2014
    Publication date: July 14, 2016
    Applicant: Merck Patent GmbH
    Inventors: Christos TSAKLAKIDIS, Wolfgang STAEHLE, Birgitta LEUTHNER
  • PEPTIDES AND PEPTIDE/ACTIVE COMPOUND CONJUGATES FOR RENAL TARGETING
    Publication number: 20160199505
    Abstract: The present invention relates to a peptide which consists of more than 50% of sequence sections of the formula -(An-Bm-Co)-, and to a conjugate containing the peptide and at least one covalently bonded active compound, and to a process for the preparation of the conjugate. The present invention furthermore relates to the use of the peptide and the conjugate for targeting of the kidney, and to a medicament comprising the peptide or conjugate.
    Type: Application
    Filed: April 16, 2014
    Publication date: July 14, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Armin KUEBELBECK, Gregor LARBIG, Stefan ARNOLD, Walter MIER
  • Quinazolinone derivatives as PARP inhibitors
    Patent number: 9388142
    Abstract: Compounds of the formula I in which R1, R2, R3, X1, X2 and Y have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
    Type: Grant
    Filed: August 27, 2013
    Date of Patent: July 12, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Dieter Dorsch, Hans-Peter Buchstaller
  • Liquid crystal mixture
    Patent number: 9388338
    Abstract: Liquid crystal mixture comprising one or several compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, M1, M2, X, A, and m are defined herein.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: July 12, 2016
    Assignee: Merck Patent GmbH
    Inventors: Ji Li, Toshiaki Nonaka, Ayako Ogawa, Hans-Rolf Dübal, Barbara Hornung, Wolfgang Schmidt, Rainer Wingen
  • Anhydrous sodium carbonate having a low pore content
    Patent number: 9388053
    Abstract: The present invention relates to a highly pure, anhydrous sodium carbonate having a low pore content for use in pharmaceutical formulations and in the foods industry. Furthermore, a novel process for the preparation of this sodium carbonate is provided.
    Type: Grant
    Filed: November 10, 2012
    Date of Patent: July 12, 2016
    Assignee: Merck Patent GmbH
    Inventors: Jens Klatyk, Hans-Kurt Peth, Thorsten Wedel, Guenter Moddelmog
  • Liquid-crystalline medium, method for the stabilization thereof, and liquid-crystal display
    Patent number: 9388339
    Abstract: The invention relates to compounds of the formula I, and to a liquid-crystalline medium, preferably having a nematic phase and negative dielectric anisotropy, which comprises a) one or more compounds of the formula I and b) one or more compounds of the formula III-O in which the parameters have the respective meanings indicated in Claim 1, to the use thereof in an electro-optical display, particularly in an active-matrix display based on the VA, ECB, PALC, FFS or IPS effect, to displays of this type which contain a liquid-crystalline medium of this type, and to the use of the compounds of the formula I for the stabilization of a liquid-crystalline medium which comprises one or more compounds of the formula III-O.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: July 12, 2016
    Assignee: MERCK PATENT GmbH
    Inventors: Mark Goebel, Eveline Baron, Rocco Fortte, Detlef Pauluth
  • Additives for dye-sensitized solar cells
    Patent number: 9390864
    Abstract: The present invention relates to the use of at least one imidazol derivative of formula I or 1-(3,3,4,4,4-pentafluorobutyl)-1H-imidazole, 1-(3,3,4,4,4-pentafluorobutyl)-1,2,3-triazole or 1-(2?-thioethyl)ethylimidazole as additive in dye-sensitized solar cells and to special electrolyte formulations and a dye-sensitized solar cell comprising at least one compound of formula I or 1-(3,3,4,4,4-pentafluorobutyl)-1H-imidazole, 1-(3,3,4,4,4-pentafluorobutyl)-1,2,3-triazole or 1-(2?-thioethyl)ethylimidazole.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: July 12, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Kentaro Kawata, Tomohisa Goto, Hiroki Yoshizaki
  • POTENT INHIBITORS OF HUMAN MATRIPTASE DERIVED FROM MCOTI-II VARIANTS
    Publication number: 20160194380
    Abstract: The present invention pertains to highly potent Matriptase inhibitors derived from the miniprotein McotI-II.
    Type: Application
    Filed: April 8, 2014
    Publication date: July 7, 2016
    Applicant: Merck Patent GmbH
    Inventors: Michael TOMASZOWSKY, Niklas WEBER, Bernhard GLOTZBACH, Harald KOLMAR, Bjoern HOCK
  • Metal complexes
    Patent number: 9382253
    Abstract: The present invention relates to metal complexes which contain polymerizable groups and to the polymers obtained using these metal complexes and to electronic devices, in particular organic electroluminescent devices, comprising these polymers. The metal complexes are compounds of the formula (1), containing a moiety M(L)n of the formula (2) or formula (3).
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Dominik Joosten, Anja Gerhard, Esther Breuning, Niels Schulte
  • 7-azaindole-2,7-naphthyridine derivative for the treatment of tumours
    Patent number: 9382244
    Abstract: The compound 4-(2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,7-naphthyridin-1-ylamine and pharmaceutically usable salts and/or tautomers thereof. The use of this compound for the treatment of tumors, tumor growth, tumor metastases and/or AIDS.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventors: Alfred Jonczyk, Frank T. Zenke, Christiane Amendt
  • Nanocrystals on fibers
    Patent number: 9385337
    Abstract: The present invention relates inter alia to light- and/or irradiation-emitting fibers comprising nanocrystals, in particular quantum dots and nanorods, their preparation and use. The fiber may have a fiber core 10, an outer first electrode 20, a light emitting layer 30, a radiation transmissive second electrode 40 positioned over the organic light emitting layer 30. Eventually the fiber may also comprise an optional radiation transmissive moisture and/or air barrier layer 50 and/or an optional radiation transmissive encapsulating material 60.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventor: Junyou Pan
  • Electrophoretic fluids
    Patent number: 9383621
    Abstract: This invention relates to electrophoretic fluids, the use of these fluids for the preparation of an electrophoretic display device, and electrophoretic displays comprising such fluids.
    Type: Grant
    Filed: November 13, 2012
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventors: Ashley Nathan Smith, Mark John Goulding